Johannes Clausen

12PUBLICATIONS
46CO-AUTHORS
Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Respiratory diseasesMedical infection agents (incl. prions)Cardiovascular medicine and haematology not elsewhere classifiedRegenerative medicine (incl. stem cells)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (12)

|Aug 26, 2026
Real-world outcomes of ide-cel and cilta-cel in relapsed/refractory multiple myeloma: A nationwide, retrospective analysis in Austria.

|Mar 28, 2026
Clinical outcomes of third-line therapy for aGvHD with gastrointestinal involvement after steroids and ruxolitinib failure.

Johannes Clausen, José Antonio Pérez Simón, Martin Carré

|Dec 30, 2025
Rapid Hematological and Molecular Response to Pegylated Interferon in WHO-Defined Pre-Fibrotic Myelofibrosis.

Sigrid Machherndl-Spandl, Marcel Kiehberger, Veronika Sygulla

|Apr 26, 2025
Allogeneic Hematopoietic Stem Cell Transplantation in Patients with Prolymphocytic Leukemia.

Christina Groiss, Stefanie Kreissl, Irene Strassl

|Apr 14, 2025
Teduglutide for treatment-refractory severe intestinal acute graft-versus-host disease - a multicenter survey.

Niklas Brehm, Francesca Biavasco, Johannes Clausen

|Oct 16, 2024
Improved Outcomes in Myelofibrosis after Allogeneic Stem-Cell Transplantation in the Era of Ruxolitinib Pretreatment and Intensified Conditioning Regimen-Single-Center Analysis.

Sigrid Machherndl-Spandl, Sarah Hannouf, Alexander Nikoloudis

Pageof 2

Frequent Collaborators

7 joint publications

Veronika Buxhofer-Ausch

7 joint publications

Irene Strassl

3 joint publications

Sigrid Machherndl-Spandl

2 joint publications

Mohamad Mohty